Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice

PURPOSE: Among chronic liver diseases, non-alcoholic fatty liver disease (NAFLD) is one of the commonest. Although empagliflozin has several therapeutic uses in treating cardiovascular and renal disorders, its impacts and mechanisms on NAFLD are poorly understood. This research aimed to examine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Shu, Ren, Qingjuan, Chen, Shuchun, Pan, Xiaoyu, Yue, Lin, Chen, Xing, Li, Zelin, Zhen, Ruoxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461752/
https://www.ncbi.nlm.nih.gov/pubmed/37645238
http://dx.doi.org/10.2147/DMSO.S422327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461752/
https://www.ncbi.nlm.nih.gov/pubmed/37645238
http://dx.doi.org/10.2147/DMSO.S422327

Ejemplares similares